Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 11.413
1.
Med Eng Phys ; 127: 104163, 2024 May.
Article En | MEDLINE | ID: mdl-38692763

Explosions in the battlefield can result in brain damage. Research on the effects of shock waves on brain tissue mainly focuses on the effects of single-orientation blast waves, while there have been few studies on the dynamic response of the human brain to directional explosions in different planes, multi-point explosions and repetitive explosions. Therefore, the brain tissue response and the intracranial pressure (ICP) caused by different blast loadings were numerically simulated using the CONWEP method. In the study of the blast in different directions, the lateral explosion blast wave was found to cause greater ICP than did blasts from other directions. When multi-point explosions occurred in the sagittal plane simultaneously, the ICP in the temporal lobe increased by 37.8 % and the ICP in the parietal lobe decreased by 17.6 %. When multi-point explosions occurred in the horizontal plane, the ICP in the frontal lobe increased by 61.8 % and the ICP in the temporal lobe increased by 12.2 %. In a study of repetitive explosions, the maximum ICP of the second blast increased by 40.6 % over that of the first blast, and that of the third blast increased by 61.2 % over that of the second blast. The ICP on the brain tissue from repetitive blasts can exceed 200 % of that of a single explosion blast wave.


Blast Injuries , Brain Injuries , Explosions , Intracranial Pressure , Humans , Brain Injuries/physiopathology , Brain Injuries/pathology , Blast Injuries/physiopathology , Blast Injuries/pathology , Brain/physiopathology , Brain/pathology
2.
Eur J Endocrinol ; 190(5): 382-390, 2024 May 02.
Article En | MEDLINE | ID: mdl-38679947

OBJECTIVE: Assessment of posttraumatic hypothalamic-pituitary dysfunctions is expected to be the most relevant assessment to offer patients with severe intracranial affection. In this study, we aim to investigate the prevalence of hypopituitarism in patients with severe acquired traumatic brain injury (TBI) compared with nontraumatic brain injury (NTBI) and to relate pituitary insufficiency to functional and patient-reported outcomes. DESIGN: This is a prospective study. METHODS: We included patients admitted for inpatient neurorehabilitation after severe TBI (N = 42) and NTBI (N = 18). The patients underwent a pituitary function assessment at a mean of 2.4 years after the injury. Functional outcome was assessed by using Functional Independence Measure and Glasgow Outcome Scale-Extended (both 1 year after discharge from neurorehabilitation) and patient-reported outcome was assessed by using Multiple Fatigue Inventory-20 and EQ-5D-3L. RESULTS: Hypopituitarism was reported in 10/42 (24%) patients with TBI and 7/18 (39%) patients with NTBI (P = .23). Insufficiencies affected 1 axis in 14/17 (82%) patients (13 hypogonadotropic hypogonadism and 1 growth hormone [GH] deficiency) and 2 axes in 3/17 (18%) patients (1 hypogonadotropic hypogonadism and GH deficiency, and 2 hypogonadotropic hypogonadism and arginin vasopressin deficiency). None had central hypoadrenalism or central hypothyroidism. In patients with both TBI and NTBI, pituitary status was unrelated to functioning and ability scores at 1 year and to patient-reported outcome scores at a mean of 2.4 years after the injury. CONCLUSION: Patients with severe acquired brain injury may develop long-term hypothalamus-pituitary insufficiency, with an equal occurrence in patients with TBI and NTBI. In both types of patients, mainly isolated deficiencies, most commonly affecting the gonadal axis, were seen. Insufficiencies were unrelated to functional outcomes and patient-reported outcomes, probably reflecting the complexity and heterogeneous manifestations in both patient groups.


Brain Injuries, Traumatic , Brain Injuries , Hypopituitarism , Patient Reported Outcome Measures , Humans , Male , Female , Adult , Hypopituitarism/etiology , Middle Aged , Prospective Studies , Brain Injuries/physiopathology , Brain Injuries/complications , Brain Injuries, Traumatic/complications , Brain Injuries, Traumatic/physiopathology , Pituitary Gland/physiopathology , Young Adult , Aged , Glasgow Outcome Scale , Pituitary Function Tests
6.
J Trace Elem Med Biol ; 78: 127189, 2023 Jul.
Article En | MEDLINE | ID: mdl-37201369

BACKGROUND: In connection with the widespread use of explosive devices in military conflicts, in particular in Ukraine, is relevant to detect the biometals changes in the cerebellum and determine the presence of their influence on the behavior changes of rats in the elevated plus maze in the acute period of a mild blast-traumatic brain injury (bTBI). METHODS: The selected rats were randomly divided into 3 groups: Group I - Experimental with bTBI (with an excess pressure of 26-36 kPa), Group II - Sham and Group III - Intact. Behavior studies was in the elevated plus maze. Brain spectral analysis was with using of energy dispersive X-ray fluorescence analysis, after obtaining the quantitative mass fractions of biometals, the ratios of Cu/Fe, Cu/Zn, Zn/Fe were calculated and the data between the three groups were compared. RESULTS: The results showed an increase in mobility in the experimental rats, which indicates functional disorders of the cerebellum in the form of maladaptation in space. Changes in cognitive activity also is an evidence of cerebellum suppression, which is indicated by changes in vertical locomotor activity. Grooming time was shortened. We established a significant increase in Cu/Fe and Zn/Fe ratios in the cerebellum, a decrease in Cu/Zn. CONCLUSIONS: Changes in the Cu/Fe, Cu/Zn, and Zn/Fe ratios in the cerebellum correlate with impaired locomotor and cognitive activity in rats in the acute posttraumatic period. Accumulation of Fe on the 1st and 3rd day leads to disturbance of the Cu and Zn balance on the 7th day and starts a "vicious cycle" of neuronal damage. Cu/Fe, Cu/Zn, and Zn/Fe imbalances are secondary factors in the pathogenesis of brain damage as a result of primary bTBI.


Blast Injuries , Brain Injuries , Cerebellum , Copper , Iron , Trace Elements , Zinc , Trace Elements/analysis , Trace Elements/metabolism , Animals , Rats , Brain Injuries/metabolism , Brain Injuries/physiopathology , Blast Injuries/metabolism , Blast Injuries/physiopathology , Cerebellum/chemistry , Cerebellum/metabolism , Cerebellum/physiopathology , Male , Rats, Wistar , Copper/analysis , Copper/metabolism , Iron/analysis , Iron/metabolism , Zinc/analysis , Zinc/metabolism , Grooming , Locomotion , Spectrometry, X-Ray Emission
7.
Ann Clin Transl Neurol ; 10(1): 32-47, 2023 01.
Article En | MEDLINE | ID: mdl-36480557

OBJECTIVE: Neonatal imaging studies report corpus callosum abnormalities after neonatal hypoxic-ischaemic encephalopathy (HIE), but corpus callosum development and relation to cognition in childhood are unknown. Using magnetic resonance imaging (MRI), we examined the relationship between corpus callosum size, microstructure and cognitive and motor outcomes at early school-age children cooled for HIE (cases) without cerebral palsy compared to healthy, matched controls. A secondary aim was to examine the impact of HIE-related neonatal brain injury on corpus callosum size, microstructure and growth. METHODS: Participants aged 6-8 years underwent MRI, the Movement Assessment Battery for Children Second Edition and Wechsler Intelligence Scale for Children Fourth Edition. Cross-sectional area, volume, fractional anisotropy and radial diffusivity of the corpus callosum and five subdivisions were measured. Multivariable regression was used to assess associations between total motor score, full-scale IQ (FSIQ) and imaging metrics. RESULTS: Adjusting for age, sex and intracranial volume, cases (N = 40) compared to controls (N = 39) demonstrated reduced whole corpus callosum area (ß = -26.9, 95% confidence interval [CI] = -53.17, -0.58), volume (ß = -138.5, 95% CI = -267.54, -9.56), fractional anisotropy and increased radial diffusivity (P < 0.05) within segments II-V. In cases, segment V area (ß = 0.18, 95% CI = 0.004, 0.35), volume (ß = 0.04, 95% CI = 0.001, 0.079), whole corpus callosum fractional anisotropy (ß = 13.8 95% CI = 0.6, 27.1) and radial diffusivity (ß = -11.3, 95% CI = -22.22, -0.42) were associated with FSIQ. Growth of the corpus callosum was restricted in cases with a FSIQ ≤85, and volume was reduced in cases with mild neonatal multifocal injury compared to white matter injury alone. INTERPRETATION: Following neonatal HIE, morphological and microstructural changes in the corpus callosum are associated with reduced cognitive function at early school age.


Brain Injuries , Cognition , Corpus Callosum , Child , Humans , Infant, Newborn , Brain Injuries/diagnostic imaging , Brain Injuries/pathology , Brain Injuries/physiopathology , Cognition/physiology , Corpus Callosum/diagnostic imaging , Corpus Callosum/pathology , Diffusion Magnetic Resonance Imaging , Magnetic Resonance Imaging , Case-Control Studies
8.
Neurology ; 98(24): e2487-e2498, 2022 06 14.
Article En | MEDLINE | ID: mdl-35470143

BACKGROUND AND OBJECTIVES: EEG is widely used for prediction of neurologic outcome after cardiac arrest. To better understand the relationship between EEG and neuronal injury, we explored the association between EEG and neurofilament light (NfL) as a marker of neuroaxonal injury, evaluated whether highly malignant EEG patterns are reflected by high NfL levels, and explored the association of EEG backgrounds and EEG discharges with NfL. METHODS: We performed a post hoc analysis of the Target Temperature Management After Out-of-Hospital Cardiac Arrest trial. Routine EEGs were prospectively performed after the temperature intervention ≥36 hours postarrest. Patients who awoke or died prior to 36 hours postarrest were excluded. EEG experts blinded to clinical information classified EEG background, amount of discharges, and highly malignant EEG patterns according to the standardized American Clinical Neurophysiology Society terminology. Prospectively collected serum samples were analyzed for NfL after trial completion. The highest available concentration at 48 or 72 hours postarrest was used. RESULTS: A total of 262/939 patients with EEG and NfL data were included. Patients with highly malignant EEG patterns had 2.9 times higher NfL levels than patients with malignant patterns and NfL levels were 13 times higher in patients with malignant patterns than those with benign patterns (95% CI 1.4-6.1 and 6.5-26.2, respectively; effect size 0.47; p < 0.001). Both background and the amount of discharges were independently strongly associated with NfL levels (p < 0.001). The EEG background had a stronger association with NfL levels than EEG discharges (R2 = 0.30 and R2 = 0.10, respectively). NfL levels in patients with a continuous background were lower than for any other background (95% CI for discontinuous, burst-suppression, and suppression, respectively: 2.26-18.06, 3.91-41.71, and 5.74-41.74; effect size 0.30; p < 0.001 for all). NfL levels did not differ between suppression and burst suppression. Superimposed discharges were only associated with higher NfL levels if the EEG background was continuous. DISCUSSION: Benign, malignant, and highly malignant EEG patterns reflect the extent of brain injury as measured by NfL in serum. The extent of brain injury is more strongly related to the EEG background than superimposed discharges. Combining EEG and NfL may be useful to better identify patients misclassified by single methods. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov NCT01020916.


Brain Injuries , Neurofilament Proteins/blood , Out-of-Hospital Cardiac Arrest , Biomarkers , Brain Injuries/blood , Brain Injuries/physiopathology , Electroencephalography , Humans , Intermediate Filaments , Out-of-Hospital Cardiac Arrest/blood , Out-of-Hospital Cardiac Arrest/physiopathology
9.
Biomed Pharmacother ; 148: 112749, 2022 Apr.
Article En | MEDLINE | ID: mdl-35219118

Intracerebral hemorrhage (ICH) is a severe, life-threatening subtype of stoke that constitutes a crucial health and socioeconomic problem worldwide. However, the current clinical treatment can only reduce the mortality of patients to a certain extent, but cannot ameliorate neurological dysfunction and has a high recurrence rate. Increasing evidence has demonstrated that mitochondrial dysfunction occurs in the early stages of brain injury and participates in all stages of secondary brain injury (SBI) after ICH. As the energy source of cells, various pathobiological processes that lead to SBI closely interact with the mitochondria, such as oxidative stress, calcium overload, and neuronal injury. In this review, we discussed the structure and function of mitochondria and the abnormal morphological changes after ICH. In addition, we discussed recent research on the involvement of mitochondrial dynamics in the pathological process of SBI after ICH and introduced the pathological variations and related molecular mechanisms of mitochondrial dysfunction in the occurrence of brain injury. Finally, we summarized the latest progress in mitochondrion-targeted agents for ICH, which provides a direction for the development of emerging therapeutic strategies targeting the mitochondria after ICH.


Brain Injuries/physiopathology , Cerebral Hemorrhage/physiopathology , Mitochondria/metabolism , Mitochondria/pathology , Animals , Antioxidants/metabolism , Apoptosis , Brain Edema/physiopathology , Brain Injuries/metabolism , Cerebral Hemorrhage/drug therapy , Cerebral Hemorrhage/metabolism , Disease Models, Animal , Humans , Inflammation/metabolism , Mice , Mitochondrial Dynamics , Neurons/metabolism , Oxidative Stress , Rats , Reactive Oxygen Species/metabolism
10.
Cells ; 11(2)2022 01 12.
Article En | MEDLINE | ID: mdl-35053358

A subarachnoid hemorrhage (SAH), leading to severe disability and high fatality in survivors, is a devastating disease. Neuro-inflammation, a critical mechanism of cerebral vasospasm and brain injury from SAH, is tightly related to prognoses. Interestingly, studies indicate that 2-[(pyridine-2-ylmethyl)-amino]-phenol (2-PMAP) crosses the blood-brain barrier easily. Here, we investigated whether the vasodilatory and neuroprotective roles of 2-PMAP were observed in SAH rats. Rats were assigned to three groups: sham, SAH and SAH+2-PMAP. SAHs were induced by a cisterna magna injection. In the SAH+2-PMAP group, 5 mg/kg 2-PMAP was injected into the subarachnoid space before SAH induction. The administration of 2-PMAP markedly ameliorated cerebral vasospasm and decreased endothelial apoptosis 48 h after SAH. Meanwhile, 2-PMAP decreased the severity of neurological impairments and neuronal apoptosis after SAH. Furthermore, 2-PMAP decreased the activation of microglia and astrocytes, expressions of TLR-4 and p-NF-κB, inflammatory markers (TNF-α, IL-1ß and IL-6) and reactive oxygen species. This study is the first to confirm that 2-PMAP has vasodilatory and neuroprotective effects in a rat model of SAH. Taken together, the experimental results indicate that 2-PMAP treatment attenuates neuro-inflammation, oxidative stress and cerebral vasospasm, in addition to ameliorating neurological deficits, and that these attenuating and ameliorating effects are conferred through the TLR-4/NF-κB pathway.


Brain Injuries/drug therapy , Brain Injuries/etiology , Inflammation/complications , Neurons/pathology , Pyridines/therapeutic use , Subarachnoid Hemorrhage/complications , Vasospasm, Intracranial/drug therapy , Vasospasm, Intracranial/etiology , Animals , Apoptosis/drug effects , Astrocytes/drug effects , Astrocytes/metabolism , Behavior, Animal/drug effects , Brain Injuries/physiopathology , Cytokines/metabolism , Inflammation/physiopathology , Inflammation Mediators/metabolism , Microglia/drug effects , Microglia/metabolism , Models, Biological , Motor Activity/drug effects , NF-kappa B/metabolism , Neurons/drug effects , Neurons/metabolism , Pyridines/pharmacology , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Severity of Illness Index , Signal Transduction , Subarachnoid Hemorrhage/physiopathology , Toll-Like Receptor 4/metabolism , Vasospasm, Intracranial/pathology , Vasospasm, Intracranial/physiopathology
11.
PLoS One ; 17(1): e0262310, 2022.
Article En | MEDLINE | ID: mdl-34986206

Neonatal brain injury may impact brain development and lead to lifelong functional impairments. Hypoxic-ischemic encephalopathy (HIE) and congenital heart disease (CHD) are two common causes of neonatal brain injury differing in timing and mechanism. Maturation of whole-brain neural networks can be quantified during development using diffusion magnetic resonance imaging (dMRI) in combination with graph theory metrics. DMRI of 35 subjects with CHD and 62 subjects with HIE were compared to understand differences in the effects of HIE and CHD on the development of network topological parameters and functional outcomes. CHD newborns had worse 12-18 month language (P<0.01) and 30 month cognitive (P<0.01), language (P = 0.05), motor outcomes (P = 0.01). Global efficiency, a metric of brain integration, was lower in CHD (P = 0.03) than in HIE, but transitivity, modularity and small-worldness were similar. After controlling for clinical factors known to affect neurodevelopmental outcomes, we observed that global efficiency was highly associated with 30 month motor outcomes (P = 0.02) in both groups. To explore neural correlates of adverse language outcomes in CHD, we used hypothesis-based and data-driven approaches to identify pathways with altered structural connectivity. We found that connectivity strength in the superior longitudinal fasciculus (SLF) tract 2 was inversely associated with expressive language. After false discovery rate correction, a whole connectome edge analysis identified 18 pathways that were hypoconnected in the CHD cohort as compared to HIE. In sum, our study shows that neonatal structural connectivity predicts early motor development after HIE or in subjects with CHD, and regional SLF connectivity is associated with language outcomes. Further research is needed to determine if and how brain networks change over time and whether those changes represent recovery or ongoing dysfunction. This knowledge will directly inform strategies to optimize neurologic functional outcomes after neonatal brain injury.


Brain Injuries/physiopathology , Brain/physiopathology , Child , Connectome/methods , Diffusion Magnetic Resonance Imaging/methods , Female , Heart Defects, Congenital/physiopathology , Humans , Hypoxia-Ischemia, Brain/physiopathology , Infant, Newborn , Longitudinal Studies , Magnetic Resonance Imaging/methods , Male , Nerve Net/physiopathology , Neural Pathways/physiopathology , Prospective Studies
12.
Ann N Y Acad Sci ; 1508(1): 23-34, 2022 02.
Article En | MEDLINE | ID: mdl-34580886

The outcome after out-of-hospital cardiac arrest has historically been grim at best. The current overall survival rate of patients admitted to a hospital is approximately 10%, making cardiac arrest one of the leading causes of death in the United States. The situation is improving with the incorporation of therapeutic temperature modulation, aggressive prevention of secondary brain injury, and improved access to advanced cardiovascular support, all of which have decreased mortality and allowed for better outcomes. Mortality after cardiac arrest is often the direct result of active withdrawal of life-sustaining therapy based on the perception that neurological recovery is not possible. This reality highlights the importance of providing accurate estimates of neurological prognosis to decision makers when discussing goals of care. The current standard of care for assessing neurological status in patients with hypoxic-ischemic encephalopathy emphasizes a multimodal approach that includes five elements: (1) neurological examination off sedation, (2) continuous electroencephalography, (3) serum neuron-specific enolase levels, (4) magnetic resonance brain imaging, and (5) somatosensory-evoked potential testing. Sophisticated decision support systems that can integrate these clinical, imaging, and biomarker and neurophysiologic data and translate it into meaningful projections of neurological outcome are urgently needed.


Brain Injuries , Electroencephalography , Evoked Potentials, Somatosensory , Heart Arrest , Hypoxia-Ischemia, Brain , Brain Injuries/etiology , Brain Injuries/mortality , Brain Injuries/physiopathology , Brain Injuries/therapy , Disease-Free Survival , Heart Arrest/complications , Heart Arrest/mortality , Heart Arrest/physiopathology , Heart Arrest/therapy , Humans , Hypoxia-Ischemia, Brain/etiology , Hypoxia-Ischemia, Brain/mortality , Hypoxia-Ischemia, Brain/physiopathology , Hypoxia-Ischemia, Brain/therapy , Magnetic Resonance Imaging , Survival Rate
13.
J Cereb Blood Flow Metab ; 42(1): 27-38, 2022 01.
Article En | MEDLINE | ID: mdl-34617816

Cerebral autoregulation is a complex mechanism that serves to keep cerebral blood flow relatively constant within a wide range of cerebral perfusion pressures. The mean flow index (Mx) is one of several methods to assess dynamic cerebral autoregulation, but its reliability and validity have never been assessed systematically. The purpose of the present systematic review was to evaluate the methodology, reliability and validity of Mx.Based on 128 studies, we found inconsistency in the pre-processing of the recordings and the methods for calculation of Mx. The reliability in terms of repeatability and reproducibility ranged from poor to excellent, with optimal repeatability when comparing overlapping recordings. The discriminatory ability varied depending on the patient populations; in general, those with acute brain injury exhibited a higher Mx than healthy volunteers. The prognostic ability in terms of functional outcome and mortality ranged from chance result to moderate accuracy.Since the methodology was inconsistent between studies, resulting in varying reliability and validity estimates, the results were difficult to compare. The optimal method for deriving Mx is currently unknown.


Brain Injuries/physiopathology , Cerebrovascular Circulation , Homeostasis , Blood Flow Velocity , Brain Injuries/mortality , Brain Injuries/therapy , Humans
14.
J Cereb Blood Flow Metab ; 42(1): 186-196, 2022 01.
Article En | MEDLINE | ID: mdl-34496662

Early brain injury (EBI) is considered an important cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). As a factor in EBI, microcirculatory dysfunction has become a focus of interest, but whether microcirculatory dysfunction is more important than angiographic vasospasm (aVS) remains unclear. Using data from 128 cases, we measured the time to peak (TTP) in several regions of interest on digital subtraction angiography. The intracerebral circulation time (iCCT) was obtained between the TTP in the ultra-early phase (the baseline iCCT) and in the subacute phase and/or at delayed cerebral ischemia (DCI) onset (the follow-up iCCT). In addition, the difference in the iCCT was calculated by subtracting the baseline iCCT from the follow-up iCCT. Univariate analysis showed that DCI was significantly increased in those patients with a prolonged baseline iCCT, prolonged follow-up iCCT, increased differences in the iCCT, and with severe aVS. Poor outcome was significantly increased in patients with prolonged follow-up iCCT and increased differences in the iCCT. Multivariate analysis revealed that increased differences in the iCCT were a significant risk factor that increased DCI and poor outcome. The results suggest that the increasing microcirculatory dysfunction over time, not aVS, causes DCI and poor outcome after aneurysmal aSAH.


Angiography, Digital Subtraction , Brain Injuries , Brain Ischemia , Cerebrovascular Circulation , Microcirculation , Subarachnoid Hemorrhage , Aged , Brain Injuries/diagnostic imaging , Brain Injuries/mortality , Brain Injuries/physiopathology , Brain Ischemia/diagnostic imaging , Brain Ischemia/mortality , Brain Ischemia/physiopathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Subarachnoid Hemorrhage/diagnostic imaging , Subarachnoid Hemorrhage/mortality , Subarachnoid Hemorrhage/physiopathology
15.
Dev Med Child Neurol ; 64(2): 192-199, 2022 02.
Article En | MEDLINE | ID: mdl-34416027

AIM: To assess the relationship between neonatal brain development and injury with early motor outcomes in infants with critical congenital heart disease (CCHD). METHOD: Neonatal brain magnetic resonance imaging was performed after open-heart surgery with cardiopulmonary bypass. Cortical grey matter (CGM), unmyelinated white matter, and cerebellar volumes, as well as white matter motor tract fractional anisotropy and mean diffusivity were assessed. White matter injury (WMI) and arterial ischaemic stroke (AIS) with corticospinal tract (CST) involvement were scored. Associations with motor outcomes at 3, 9, and 18 months were corrected for repeated cardiac surgery. RESULTS: Fifty-one infants (31 males, 20 females) were included prospectively. Median age at neonatal surgery and postoperative brain magnetic resonance imaging was 7 days (interquartile range [IQR] 5-11d) and 15 days (IQR 12-21d) respectively. Smaller CGM and cerebellar volumes were associated with lower fine motor scores at 9 months (CGM regression coefficient=0.51, 95% confidence interval [CI]=0.15-0.86; cerebellum regression coefficient=3.08, 95% CI=1.07-5.09) and 18 months (cerebellum regression coefficient=2.08, 95% CI=0.47-5.12). The fractional anisotropy and mean diffusivity of white matter motor tracts were not related with motor scores. WMI was related to lower gross motor scores at 9 months (mean difference -0.8SD, 95% CI=-1.5 to -0.2). AIS with CST involvement increased the risk of gross motor problems and muscle tone abnormalities. Cerebral palsy (n=3) was preceded by severe ischaemic brain injury. INTERPRETATION: Neonatal brain development and injury are associated with fewer favourable early motor outcomes in infants with CCHD.


Brain Injuries , Cerebral Palsy , Child Development/physiology , Developmental Disabilities , Heart Defects, Congenital/surgery , Ischemic Stroke , Motor Skills/physiology , Pyramidal Tracts , Brain Injuries/diagnostic imaging , Brain Injuries/pathology , Brain Injuries/physiopathology , Cerebellum/diagnostic imaging , Cerebellum/growth & development , Cerebellum/pathology , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/growth & development , Cerebral Cortex/pathology , Cerebral Palsy/diagnostic imaging , Cerebral Palsy/pathology , Cerebral Palsy/physiopathology , Developmental Disabilities/diagnostic imaging , Developmental Disabilities/etiology , Developmental Disabilities/pathology , Developmental Disabilities/physiopathology , Female , Gray Matter/diagnostic imaging , Gray Matter/growth & development , Gray Matter/pathology , Heart Defects, Congenital/complications , Heart Defects, Congenital/diagnostic imaging , Humans , Infant , Infant, Newborn , Ischemic Stroke/diagnostic imaging , Ischemic Stroke/pathology , Ischemic Stroke/physiopathology , Magnetic Resonance Imaging , Male , Prospective Studies , Pyramidal Tracts/diagnostic imaging , Pyramidal Tracts/growth & development , Pyramidal Tracts/pathology , White Matter/diagnostic imaging , White Matter/growth & development , White Matter/pathology
16.
Dev Med Child Neurol ; 64(3): 340-346, 2022 03.
Article En | MEDLINE | ID: mdl-34449080

AIM: To investigate whether children with perinatal brain injury have impairments in specific components of visual attention, and whether early dietary supplementation can reduce any deficits. METHOD: Children participating in the Dolphin neonatal trial of dietary supplementation were tested at age 6 months with the Infant Fixation Shift Attention Test, and at 4 to 5 years with four subtests of the Early Childhood Attention Battery (ECAB) assessing different components of attention (selective, sustained, and executive function), and the Fluid Crystallized Intelligence Index of the Kaufman Assessment Battery for Children, Second Edition (KABC-II). From 59 children originally assigned to trial groups, 33 were available for testing at 4 to 5 years (18 treatment group of whom seven, six, and five showed mild, moderate, or severe neonatal brain injury; 15 controls with one, seven, and seven in the neonatal brain injury categories respectively). Given the imbalance in numbers with mild brain injury, analysis of trial group differences is restricted to moderate and severe brain injury severities (n=25). RESULTS: Children with perinatal brain injury showed poorer attention across all components relative to age norms (mean standard scores 75-87; p<0.001 for three of the four subtests), with the greatest impairment in sustained attention. These impairments remained when compared with cognitive age assessed using the Fluid Crystallized Intelligence Index. Impairment was reduced in the treatment compared to the control group (p=0.04 for flanker test, p=0.002 for counterpointing, and p=0.027 for the overall ECAB score). INTERPRETATION: Perinatal brain injury is associated with later impaired attention, beyond that predicted from any general cognitive disability. Impairment varies across attention components, being most severe for sustained attention. The effects on flanker and counterpointing suggest that dietary supplementation from 0 to 2 years of age may reduce attention problems. Measuring the different components of attention is important when considering assessment and interventions for children with perinatal brain injury.


Attention/physiology , Brain Injuries , Cognitive Dysfunction , Dietary Supplements , Executive Function/physiology , Infant, Newborn, Diseases , Intelligence/physiology , Brain Injuries/complications , Brain Injuries/physiopathology , Child, Preschool , Cognitive Dysfunction/diet therapy , Cognitive Dysfunction/etiology , Cognitive Dysfunction/physiopathology , Female , Humans , Infant , Infant, Newborn , Infant, Newborn, Diseases/physiopathology , Longitudinal Studies , Male , Patient Acuity , Treatment Outcome
17.
Am J Respir Crit Care Med ; 205(2): 171-182, 2022 01 15.
Article En | MEDLINE | ID: mdl-34748722

Rationale: Predicting recovery of consciousness in unresponsive, brain-injured individuals has crucial implications for clinical decision-making. Propofol induces distinctive brain network reconfiguration in the healthy brain as it loses consciousness. In patients with disorders of consciousness, the brain network's reconfiguration to propofol may reveal the patient's underlying capacity for consciousness. Objectives: To design and test a new metric for the prognostication of consciousness recovery in disorders of consciousness. Methods: Using a within-subject design, we conducted an anesthetic protocol with concomitant high-density EEG in 12 patients with a disorder of consciousness after a brain injury. We quantified the reconfiguration of EEG network hubs and directed functional connectivity before, during, and after propofol exposure and obtained an index of propofol-induced network reconfiguration: the adaptive reconfiguration index. We compared the index of patients who recovered consciousness 3 months after EEG (n = 3) to that of patients who did not recover or remained in a chronic disorder of consciousness (n = 7) and conducted a logistic regression to assess prognostic accuracy. Measurements and Main Results: The adaptive reconfiguration index was significantly higher in patients who later recovered full consciousness (U value = 21, P = 0.008) and able to discriminate with 100% accuracy whether the patient recovered consciousness. Conclusions: The adaptive reconfiguration index of patients who recovered from a disorder of consciousness at 3-month follow-up was linearly separable from that of patients who did not recover or remained in a chronic disorder of consciousness on the single-subject level. EEG and propofol can be administered at the bedside with few contraindications, affording the adaptive reconfiguration index tremendous translational potential as a prognostic measure of consciousness recovery in acute clinical settings.


Brain Injuries/chemically induced , Brain Injuries/physiopathology , Coma/chemically induced , Coma/physiopathology , Consciousness Disorders/chemically induced , Consciousness Disorders/physiopathology , Consciousness/drug effects , Propofol/adverse effects , Adolescent , Adult , Aged , Anesthesia Recovery Period , Female , Forecasting , Humans , Male , Middle Aged , Predictive Value of Tests , Recovery of Function/drug effects , Young Adult
18.
Cell Rep ; 37(12): 110142, 2021 12 21.
Article En | MEDLINE | ID: mdl-34936876

GABAergic synaptic inhibition controls neuronal firing, excitability, and synaptic plasticity to regulate neuronal circuits. Following an acute excitotoxic insult, inhibitory synapses are eliminated, reducing synaptic inhibition, elevating circuit excitability, and contributing to the pathophysiology of brain injuries. However, mechanisms that drive inhibitory synapse disassembly and elimination are undefined. We find that inhibitory synapses are disassembled in a sequential manner following excitotoxicity: GABAARs undergo rapid nanoscale rearrangement and are dispersed from the synapse along with presynaptic active zone components, followed by the gradual removal of the gephyrin scaffold, prior to complete elimination of the presynaptic terminal. GABAAR nanoscale reorganization and synaptic declustering depends on calcineurin signaling, whereas disassembly of gephyrin relies on calpain activation, and blockade of both enzymes preserves inhibitory synapses after excitotoxic insult. Thus, inhibitory synapse disassembly occurs rapidly, with nanoscale precision, in a stepwise manner and most likely represents a critical step in the progression of hyperexcitability following excitotoxicity.


Brain Injuries/physiopathology , Membrane Proteins/metabolism , Neurons/metabolism , Presynaptic Terminals/metabolism , Receptors, GABA-A/metabolism , Synapses/metabolism , Animals , Female , Male , Mice, Inbred C57BL , Neuronal Plasticity , Rats , Rats, Sprague-Dawley , Signal Transduction
19.
Sci Rep ; 11(1): 22952, 2021 11 25.
Article En | MEDLINE | ID: mdl-34824383

To determine the role of early acquisition of blood oxygen level-dependent (BOLD) signals and diffusion tensor imaging (DTI) for analysis of the connectivity of the ascending arousal network (AAN) in predicting neurological outcomes after acute traumatic brain injury (TBI), cardiopulmonary arrest (CPA), or stroke. A prospective analysis of 50 comatose patients was performed during their ICU stay. Image processing was conducted to assess structural and functional connectivity of the AAN. Outcomes were evaluated after 3 and 6 months. Nineteen patients (38%) had stroke, 18 (36%) CPA, and 13 (26%) TBI. Twenty-three patients were comatose (44%), 11 were in a minimally conscious state (20%), and 16 had unresponsive wakefulness syndrome (32%). Univariate analysis demonstrated that measurements of diffusivity, functional connectivity, and numbers of fibers in the gray matter, white matter, whole brain, midbrain reticular formation, and pontis oralis nucleus may serve as predictive biomarkers of outcome depending on the diagnosis. Multivariate analysis demonstrated a correlation of the predicted value and the real outcome for each separate diagnosis and for all the etiologies together. Findings suggest that the above imaging biomarkers may have a predictive role for the outcome of comatose patients after acute TBI, CPA, or stroke.


Consciousness Disorders , Neural Pathways , Adult , Aged , Arousal , Biomarkers , Brain/diagnostic imaging , Brain/physiopathology , Brain Injuries/physiopathology , Brain Injuries, Traumatic/complications , Brain Injuries, Traumatic/diagnosis , Coma/diagnostic imaging , Coma/etiology , Coma/physiopathology , Consciousness/physiology , Consciousness Disorders/diagnostic imaging , Consciousness Disorders/etiology , Consciousness Disorders/physiopathology , Diffusion Tensor Imaging , Female , Heart Arrest/complications , Heart Arrest/diagnosis , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged , Neural Pathways/diagnostic imaging , Neural Pathways/physiopathology , Oxygen Saturation , Prognosis , Stroke/complications , Stroke/diagnosis
20.
J Pharmacol Exp Ther ; 379(3): 310-323, 2021 12.
Article En | MEDLINE | ID: mdl-34593559

Mounting evidence suggests the synaptic vesicle glycoprotein 2A (SV2A) targeted by levetiracetam may contribute to epileptogenesis. Levetiracetam has shown anti-inflammatory, antioxidant, neuroprotective, and possible antiepileptogenic effects in brain injury and seizure/epilepsy models, and a phase 2 study has signaled a possible clinical antiepileptogenic effect. Brivaracetam shows greater affinity and specificity for SV2A than levetiracetam and broader preclinical antiseizure effects. Thus, we assessed the antiepileptogenic/disease-modifying potential of brivaracetam in an etiologically realistic rat posttraumatic epilepsy model optimized for efficient drug testing. Brivaracetam delivery protocols were designed to maintain clinical moderate-to-high plasma levels in young (5-week-old) male Sprague-Dawley rats for 4 weeks. Treatment protocols were rapidly screened in 4-week experiments using small groups of animals to ensure against rigorous testing of futile treatment protocols. The antiepileptogenic effects of brivaracetam treatment initiated 30 minutes, 4 hours, and 8 hours after rostral parasagittal fluid percussion injury (rpFPI) were then compared with vehicle-treated controls in a fully powered blind and randomized 16-week validation. Seizures were evaluated by video-electrocorticography using a 5-electrode epidural montage. Endpoint measures included incidence, frequency, duration, and spread of seizures. Group sizes and recording durations were supported by published power analyses. Three months after treatment ended, rats treated with brivaracetam starting at 4 hours post-FPI (the best-performing protocol) experienced a 38% decrease in overall incidence of seizures, 59% decrease in seizure frequency, 67% decrease in time spent seizing, and a 45% decrease in the proportion of spreading seizures that was independent of duration-based seizure definition. Thus, brivaracetam shows both antiepileptogenic and disease-modifying properties after rpFPI. SIGNIFICANCE STATEMENT: The rpFPI model, which likely incorporates epileptogenic mechanisms operating after human head injury, can be used to efficiently screen investigational treatment protocols and assess antiepileptogenic/disease-modifying effects. Our studies 1) support a role for SV2A in epileptogenesis, 2) suggest that brivaracetam and other drugs targeting SV2A should be considered for human clinical trials of prevention of post-traumatic epilepsy after head injury, and 3) provide data to inform the design of treatment protocols for clinical trials.


Anticonvulsants/administration & dosage , Brain Injuries/drug therapy , Epilepsy, Post-Traumatic/drug therapy , Pyrrolidinones/administration & dosage , Animals , Anticonvulsants/blood , Brain Injuries/blood , Brain Injuries/physiopathology , Drug Administration Schedule , Electrocorticography/methods , Epilepsy, Post-Traumatic/blood , Epilepsy, Post-Traumatic/physiopathology , Male , Pilot Projects , Pyrrolidinones/blood , Rats , Rats, Sprague-Dawley , Treatment Outcome
...